Table 5 Health economics data of all patients enrolled
From: The impact of COVID-19 on gastric cancer surgery: a single-center retrospective study
Health economics data (10,000 RMB) | PCG(N = 68) M (IQR) | CG (N = 41) M (IQR) | P |
|---|---|---|---|
Medicine | 2.51 (1.79–3.27) | 2.89 (2.29–4.30) | 0.002* |
Examination | 0.05 (0.03–0.09) | 0.06 (0.05–0.08) | 0.051 |
Laboratory test | 0.83 (0.68–1.06) | 1.00 (0.76–1.18) | 0.078 |
Treatment | 7.99 (6.59–9.66) | 9.00 (7.59–11.09) | 0.024* |
Surgery | 0.46 (0.45–0.47) | 0.47 (0.40–0.47) | 0.527 |
Anesthesia | 0.20 (0.18–0.23) | 0.22 (0.19–0.23) | 0.131 |
Consumables | 3.94 (3.55–4.50) | 4.45 (3.45–5.45) | 0.140 |
Others | 0.26 (0.21–0.34) | 0.47 (0.36–0.54) | 0.000* |
Total costs | 9.23 (7.82–10.97) | 10.42 (8.99–12.57) | 0.006* |